Back to Journals » OncoTargets and Therapy » Volume 4

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer

Total article views   HTML views PDF downloads Totals
13,097 Dovepress* 10,785+ 1,740 12,525
PubMed Central* 2,312 630 2,942
Totals 13,097 2,370 15,467
*Since 14 November 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar